Compounds and compositions as TLR activity modulators

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9045470
APP PUB NO 20110053893A1
SERIAL NO

12874153

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides a novel class of compounds, immunogenic compositions and pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with Toll-Like Receptors 7. In one aspect, the compounds are useful as adjuvants for enhancing the effectiveness of a vaccine.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS AGBASEL SUI

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cortez, Alex San Diego, US 14 174
Li, Yongkai San Diego, US 22 163
Singh, Manmohan Lexington, US 103 2287
Skibinski, David Siena, IT 9 141
Wu, Tom Yao Hsiang San Diego, US 4 77
Yue, Kathy Riverside, US 5 92
Zhang, Xiaoyue San Diego, US 19 190

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 2, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00